AI Bioweapons Risk: What Anthropic’s Report Means for Pharma
The Anthropic 2026 threat report documents a significant bioweapons risk. See what this means for pharma biosecurity, research, and AI controls.
Browse Pharmatica main sections, topics, interview series, and company pages.
Type at least 2 characters to search
AI Bioweapons Risk: What Anthropic’s Report Means for Pharma
The Anthropic 2026 threat report documents a significant bioweapons risk. See what this means for pharma biosecurity, research, and AI controls.
AI Creates New Viruses? Not Quite. AI-Designed Bacteriophages
AI-designed bacteriophages show how genome models could create new antibacterial therapies while forcing pharma to rethink biological AI governance and biosecurity.
Ketryx and Accenture Build Regulated AI MedTech at Scale
Ketryx and Accenture are combining AI-native compliance infrastructure and transformation expertise to help MedTech scale regulated AI without slowing development.
How AI Is Reshaping Data Integrity in Pharma Manufacturing
Veragence CEO Nour AlSaleh discusses how AI is transforming data integrity in pharma manufacturing, regulatory compliance, the "human-in-the-loop" requirement, and patient safety in the era of AI-driven GxP systems.
Throne Science: Passive Health Monitoring in the Bathroom
Read about how Throne Science is advancing passive health monitoring with AI-powered sensing that automatically captures daily toilet habit data.
Digital Health Technologies in Clinical Drug Development
Digital health technologies in clinical drug development need more than data. Explore validation, standards, digital endpoints, patient value, and regulation.
No result found for